Michael N. Orlando

Array ( [id] => 20288660 [patent_doc_number] => 20250313903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-09 [patent_title] => NEOANTIGEN IMMUNOTHERAPY [patent_app_type] => utility [patent_app_number] => 19/240318 [patent_app_country] => US [patent_app_date] => 2025-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59553 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19240318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19572226 [patent_doc_number] => 20240376518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => METHOD FOR DETECTING TARGET NUCLEIC ACIDS USING PLASMONIC IMMUNOMAGNETIC NANOPARTICLES [patent_app_type] => utility [patent_app_number] => 18/584279 [patent_app_country] => US [patent_app_date] => 2024-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4780 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18584279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19361185 [patent_doc_number] => 20240263219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => METHODS AND COMPOSITIONS FOR IN SITU ANALYSIS OF VARIANT SEQUENCES [patent_app_type] => utility [patent_app_number] => 18/405884 [patent_app_country] => US [patent_app_date] => 2024-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42057 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18405884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19449329 [patent_doc_number] => 20240309459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => METHOD OF IDENTIFYING FEATURE OF TEST BODY AND MICRORNA CANCER MARKER [patent_app_type] => utility [patent_app_number] => 18/524141 [patent_app_country] => US [patent_app_date] => 2023-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8988 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18524141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19083431 [patent_doc_number] => 20240110232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-04 [patent_title] => GENE SPECIFIC TISSUE INFORMATION AND SEQUENCING [patent_app_type] => utility [patent_app_number] => 18/373441 [patent_app_country] => US [patent_app_date] => 2023-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2721 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 302 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18373441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19051308 [patent_doc_number] => 20240093277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => SYSTEM FOR PERFORMING NUCLEIC ACID AMPLIFICATION ASSAYS [patent_app_type] => utility [patent_app_number] => 18/361797 [patent_app_country] => US [patent_app_date] => 2023-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 86618 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 358 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18361797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19281984 [patent_doc_number] => 20240218458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => A MULTIPLEX CRISPR BASED ASSAY FOR THE SIMULTANEOUS DETECTION OF CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE [patent_app_type] => utility [patent_app_number] => 18/332359 [patent_app_country] => US [patent_app_date] => 2023-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17705 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18332359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18726337 [patent_doc_number] => 20230340614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => TREATING TUMORS RESULTING IN OR FROM CNS METASTASIS USING MDM2/4 AND CDKN2A INHIBITORS [patent_app_type] => utility [patent_app_number] => 18/139402 [patent_app_country] => US [patent_app_date] => 2023-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5414 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18139402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18786451 [patent_doc_number] => 20230374570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => METHOD AND SYSTEM FOR DETECTING FUNGAL GENES AND KIT FOR USE WITH SAME [patent_app_type] => utility [patent_app_number] => 18/295613 [patent_app_country] => US [patent_app_date] => 2023-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12768 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18295613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18626228 [patent_doc_number] => 20230285009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => N-myristoyltransferase 2 Overexpression in Peripheral Blood and Peripheral Blood Mononuclear Cells is a Marker for Colorectal Cancer [patent_app_type] => utility [patent_app_number] => 18/183393 [patent_app_country] => US [patent_app_date] => 2023-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7764 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18183393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18612731 [patent_doc_number] => 20230279465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => METHODS OF ANCHORING FRAGMENTED NUCLEIC ACID TARGETS IN A POLYMER MATRIX FOR IMAGING [patent_app_type] => utility [patent_app_number] => 18/111070 [patent_app_country] => US [patent_app_date] => 2023-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26851 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18111070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18844994 [patent_doc_number] => 20230407398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => Methods and Systems for Detecting Methylation of Fragile X [patent_app_type] => utility [patent_app_number] => 18/107877 [patent_app_country] => US [patent_app_date] => 2023-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17196 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18107877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18862397 [patent_doc_number] => 20230416833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => SYSTEMS AND METHODS FOR MONITORING OF CANCER USING MINIMAL RESIDUAL DISEASE ANALYSIS [patent_app_type] => utility [patent_app_number] => 18/105113 [patent_app_country] => US [patent_app_date] => 2023-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27748 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18105113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19318720 [patent_doc_number] => 20240240263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-18 [patent_title] => NUCLEIC ACID DETECTION REAGENT AND DETECTION METHOD FOR MYCOBACTERIUM TUBERCULOSIS [patent_app_type] => utility [patent_app_number] => 18/098196 [patent_app_country] => US [patent_app_date] => 2023-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4308 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18098196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18708032 [patent_doc_number] => 20230330617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => FLOW CELL SURFACE PATTERNING [patent_app_type] => utility [patent_app_number] => 18/145843 [patent_app_country] => US [patent_app_date] => 2022-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29067 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18145843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18406157 [patent_doc_number] => 20230167508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => CELL-FREE DNA SIZE DETECTION [patent_app_type] => utility [patent_app_number] => 18/054676 [patent_app_country] => US [patent_app_date] => 2022-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23450 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18054676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18485349 [patent_doc_number] => 20230212686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => KIT AND METHOD FOR DETECTING TARGET NUCLEIC ACIDS USING MAGNETIC NANOPARTICLES [patent_app_type] => utility [patent_app_number] => 17/980974 [patent_app_country] => US [patent_app_date] => 2022-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11105 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17980974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18266515 [patent_doc_number] => 20230087757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => SYSTEMS AND METHODS FOR USING TRAPPED CHARGE FOR BILAYER FORMATION AND PORE INSERTION IN A NANOPORE ARRAY [patent_app_type] => utility [patent_app_number] => 18/051619 [patent_app_country] => US [patent_app_date] => 2022-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17584 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18051619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18693056 [patent_doc_number] => 20230323442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => CIRCULATING SERUM MICRORNA BIOMARKERS AND METHODS [patent_app_type] => utility [patent_app_number] => 18/045065 [patent_app_country] => US [patent_app_date] => 2022-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4923 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18045065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18628521 [patent_doc_number] => 20230287386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => STABILIZATION OF NUCLEIC ACIDS IN BIOLOGICAL SAMPLES [patent_app_type] => utility [patent_app_number] => 17/961273 [patent_app_country] => US [patent_app_date] => 2022-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6070 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17961273 [rel_patent_id] =>[rel_patent_doc_number] =>)